Neuroimaging in amyotrophic lateral sclerosis.

Martin R Turner1, Federica Agosta, Peter Bede

  • 1Nuffield Department of Clinical Neurosciences, Oxford University, UK. martin.turner@ndcn.ox.ac.uk

Summary

Neuroimaging advances, particularly MRI, offer new insights into amyotrophic lateral sclerosis (ALS) and its extra-motor pathology. These techniques reveal biomarkers crucial for understanding this complex neurodegenerative disease.

Related Concept Videos